TLR8 agonist 10
TLR8 agonist 10 is a selective TLR8 agonist with an EC50 of 0.019 μM in humans. TLR8 agonist 10 activates TLR8-mediated signaling pathways. As a latency-reversing agent, TLR8 agonist 10 reactivates latent HIV-1 reservoirs. TLR8 agonist 10 activates innate cytotoxic natural killer cells to target HIV-infected CD4+ T cells. TLR8 agonist 10 is applicable to research related to HIV-1 infection.
For research use only. We do not sell to patients.
- CAS No.: 2796210-93-8
- Formula: C20H30N4
- Molecular Weight:326.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
HIV-1 |
hTLR8 0.019 μM (IC50) |
TLR8 agonist 10 (Compound 23A) (0-10 μM) potently reactivates latent HIV-1 in U1 cells in vitro without significant cytotoxicity[1].
TLR8 agonist 10 (0-10 μM) can indirectly activate latent HIV-1 in ACH-2 cells via cytokine signals produced by treated human PBMCs, and exhibits no significant cytotoxicity against ACH-2 cells[1].
TLR8 agonist 10 (0-10 μM) potently reactivates latent HIV-1 in OM10.1 cells in a concentration-dependent manner, with no significant cytotoxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2796210-93-8
-
Molecular Weight 326.48
-
Formula C20H30N4
-
SMILES
CCCCNC1=CC(CC2=CC=C(C=C2)CN(C)C)=C(N=C1N)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)